Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications.

Saved in:
Bibliographic Details
Title: Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications.
Authors: Wang X; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China., Ni R; Institute for Biomedical Engineering, ETH Zurich & University of Zurich, Zurich, Switzerland.; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Inselspital, Bern, Switzerland., Wang X; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. wangxiaohuia@gdpu.edu.cn.; Department of Nuclear Medicine, The First Hospital of Lanzhou University, Lanzhou, China. wangxiaohuia@gdpu.edu.cn., Li X; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. lxdr21@126.com.; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. lxdr21@126.com.; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China. lxdr21@126.com.
Source: Molecular cancer [Mol Cancer] 2026 Mar 06; Vol. 25 (1). Date of Electronic Publication: 2026 Mar 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4598
DOI:10.1186/s12943-025-02559-5